CN102188650A - Traditional Chinese drug for treating diabetic acral necrosis - Google Patents

Traditional Chinese drug for treating diabetic acral necrosis Download PDF

Info

Publication number
CN102188650A
CN102188650A CN2010106043638A CN201010604363A CN102188650A CN 102188650 A CN102188650 A CN 102188650A CN 2010106043638 A CN2010106043638 A CN 2010106043638A CN 201010604363 A CN201010604363 A CN 201010604363A CN 102188650 A CN102188650 A CN 102188650A
Authority
CN
China
Prior art keywords
traditional chinese
chinese drug
parts
blood
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010106043638A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2010106043638A priority Critical patent/CN102188650A/en
Publication of CN102188650A publication Critical patent/CN102188650A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese drug for treating diabetic acral necrosis, and belongs to the traditional Chinese drug field of diabetes curing. The traditional Chinese drug is characterized by fine curative effect and immediate effect. The traditional Chinese drug is composed of the following raw materials: purslane, Chinese angelica, dan-shen root, lucid ganoderma, sanchi, Chinaroot greenbrier rhizome and the like. The traditional Chinese drug has effects of strengthening body resistance, cultivating constitution, supplementing qi and nourishing blood, activating blood and dissolving stasis, clearing heat and removing dampness, and has advantages of significant effect, exact curative effect and quick results.

Description

A kind of Chinese medicine for the treatment of acromegaly necrosis diabetes
Technical field
The invention belongs to the field of Chinese medicines of treatment diabetes.
Background technology
Acromegaly necrosis diabetes is the complication of the common pilosity of diabetes, is due to diabetictrunk angiopathy and the neuropathy.The treatment difficulty is very big, is a domestic treatment " difficult problem " of not capturing as yet at present.The Western medicine and the Chinese medicine that are used for the treatment of acromegaly necrosis diabetes at present, exist some significantly not enough: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, antibiotic is invalid to this in addition, a large amount of patients feel simply helpless in the face of acromegaly necrosis diabetes, suffer from the limb obstinate, constantly worsen, be compelled to do at last " amputation " operation, cause the maimed person.The patient spends the money of oneself, saws the lower limb of oneself, and is painful and helpless!
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Portulacae 5---18 parts of 15 parts of Radix Angelicae Sinensis 6---18 parts of Radix Salviae Miltiorrhizaes 6---
Ganoderma 6---18 parts of 18 portions of Radix Notoginseng 3---9 portions of Rhizoma Smilacis Chinensiss 6---
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hours, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with hot water (95 ℃) lixiviate of 1:20 → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Portulacae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, the conventional water extraction process of Rhizoma Smilacis Chinensis are extracted, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that the pathogenesis of acromegaly necrosis diabetes mainly belongs to " heat " and " stasis of blood " at research.The most of hypoimmunities of diabetics, cloudy liquid loses empty, gives birth in the deficiency-heat, consumes the body fluid that burns, and causes hyperlipidemia, the resistance of the blood vessel stasis of blood, blood flow is slow, suffers from the limb blood supply insufficiency.This is a main cause of suffering from limb generation macroangiopathy and neuropathy.In view of the above, the present invention attaches most importance to set upright, clearing away heat-damp and promoting diuresis detoxifcation, the promoting flow of QI and blood blood stasis dispelling, on therapeutic effect, obtained breakthrough---western medicine and medical practitioners can only " amputation " acromegaly necrosis diabetes, use the present invention can " amputation ", make and suffer from limb and rehabilitate.We can say that this is a comparatively great invention.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, the tonification the five internal organs, enhancing human body immunity power, this is the important prerequisite of repairing vascular lesion, neuropathy; Radix Salviae Miltiorrhizae, Radix Notoginseng blood-supplementing blood-nourishing, blood circulation and channel invigorating, blood-activating analgetic, Ganoderma, Radix Angelicae Sinensis and Radix Salviae Miltiorrhizae, Radix Notoginseng are associated with, and the prosperous hemapodium of gas promotes blood clean, flow faster, blood stasis removing blood slough and tissue regeneration promoting flesh; 5 with the Herba Portulacae heat-clearing and toxic substances removing, removing heat from blood, antibiotic; The Rhizoma Smilacis Chinensis expelling wind and removing dampness, detoxifcation dissipating blood stasis, the kind chronic limbs ulcer of outbreak repeatedly of controlling.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of clearing away heat-damp and promoting diuresis, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Portulacae 60 gram Radix Angelicae Sinensis 70 gram Radix Salviae Miltiorrhizaes 70 grams
Ganoderma 70 gram Radix Notoginseng 30 gram Rhizoma Smilacis Chinensiss 70 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Herba Portulacae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Smilacis Chinensis are extracted, make extract fine powder 68 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 350 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Portulacae 90 gram Radix Angelicae Sinensis 120 gram Radix Salviae Miltiorrhizaes 120 grams
Ganoderma 120 gram Radix Notoginseng 50 gram Rhizoma Smilacis Chinensiss 120 grams
By above-mentioned same method, make 585 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Portulacae 150 gram Radix Angelicae Sinensis 180 gram Radix Salviae Miltiorrhizaes 180 grams
Ganoderma 180 gram Radix Notoginseng 80 gram Rhizoma Smilacis Chinensiss 180 grams
By above-mentioned same method, make 907 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
9 parts of 9 parts of Radix Salviae Miltiorrhizaes of 7 parts of Radix Angelicae Sinensis of Herba Portulacae
9 parts of 4 portions of Rhizoma Smilacis Chinensiss of 9 portions of Radix Notoginseng of Ganoderma
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 16 parts of Radix Salviae Miltiorrhizaes of 13 parts of Radix Angelicae Sinensis of Herba Portulacae
16 parts of 7 portions of Rhizoma Smilacis Chinensiss of 16 portions of Radix Notoginseng of Ganoderma
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science acromegaly necrosis diabetes, through 6 routine clinical observations.Selecting the tcm diagnosis acromegaly necrosis diabetes is standard: the diabetics emaciated physique, and limb is soft weak; Suffer from limb and send out cold, poor blood circulation; Amyotrophy; The lower limb weak and faint pulse, intermittent claudication; Suffer from limb skin blackout, blue, tissue necrosis; Numb limbs and tense tendons, acrodynia; Suffer from limb acra ulcer, fester, bleed and suppurate, disunion for a long time.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 2 examples do not have other serious disease, and the age is 49 years old-78 years old, 65.3 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Limbs are warm, send out cool the disappearance; Skin color is progressively bleached (normal skin color) by black purple, and blood circulation obviously improves; Trouble acroanesthesia, acrodynia obviously alleviate; Acra fester alleviation, the healing.
2, effective: body constitution strengthens, and on one's body energetically, limbs are warm, and blood circulation improves; Numb limbs and tense tendons, pain are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, except that hypoglycemic medicine, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.6 philtrums of clinical experiment, produce effects 2 people, effective 3 people, invalid 1 people, total effective rate 83.3%.

Claims (1)

1. Chinese medicine for the treatment of acromegaly necrosis diabetes, it is characterized in that: it is to make with the component of following weight ratio: Herba Portulacae 5---15 parts, Radix Angelicae Sinensis 6---18 parts, Radix Salviae Miltiorrhizae 6---18 parts, Ganoderma 6---18 parts, Radix Notoginseng 3---9 parts, Rhizoma Smilacis Chinensis 6---18 parts.
CN2010106043638A 2010-12-24 2010-12-24 Traditional Chinese drug for treating diabetic acral necrosis Pending CN102188650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010106043638A CN102188650A (en) 2010-12-24 2010-12-24 Traditional Chinese drug for treating diabetic acral necrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010106043638A CN102188650A (en) 2010-12-24 2010-12-24 Traditional Chinese drug for treating diabetic acral necrosis

Publications (1)

Publication Number Publication Date
CN102188650A true CN102188650A (en) 2011-09-21

Family

ID=44598085

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010106043638A Pending CN102188650A (en) 2010-12-24 2010-12-24 Traditional Chinese drug for treating diabetic acral necrosis

Country Status (1)

Country Link
CN (1) CN102188650A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103212000A (en) * 2012-03-06 2013-07-24 杜中勤 Preparation method of drug treating unhealed wound of diabetic patient

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103212000A (en) * 2012-03-06 2013-07-24 杜中勤 Preparation method of drug treating unhealed wound of diabetic patient
CN103212000B (en) * 2012-03-06 2014-05-28 常美 Preparation method of drug treating unhealed wound of diabetic patient

Similar Documents

Publication Publication Date Title
CN102091264A (en) Traditional Chinese medicine for treating diabetic foot
CN101954024A (en) Traditional Chinese medicament for treating diabetic foot
CN102380063A (en) Chinese medicament for treating diabetic foot
CN102389547A (en) Traditional Chinese medicine for treating diabetic foot
CN102114213A (en) Traditional Chinese medicine for treating diabetic acral necrosis
CN102139076A (en) Traditional Chinese medicine for treating diabetic foot
CN101972367A (en) Traditional Chinese medicine for treating diabetic peripheral neuropathy
CN102389544A (en) Traditional Chinese medicine for treating diabetic foot
CN102380065A (en) Traditional Chinese medicine for treating diabetic feet
CN102188650A (en) Traditional Chinese drug for treating diabetic acral necrosis
CN101972438A (en) Traditional Chinese medicine for treating diabetic acral necrosis
CN102172391A (en) Traditional Chinese medicine for treating diabetic foot
CN102018765A (en) Traditional Chinese medicine for treating diabetic acromelic gangrene
CN101972439A (en) Traditional Chinese medicine for treating diabetic foot
CN102188651A (en) Traditional Chinese medicine for treating diabetic feet
CN101961471A (en) Traditional Chinese medicine for treating diabetic foot
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN102380067A (en) Traditional Chinese medicine for treating diabetic foot
CN101983705A (en) Traditional Chinese medicine for treating diabetic acra necrosis
CN102114214A (en) Chinese medicine for treating diabetic foot
CN101961470A (en) Traditional Chinese medicine for treating diabetic acral necrosis
CN101979064A (en) Traditional Chinese medicine for treating diabetic limb amputation
CN101954025A (en) Traditional Chinese medicine for treating diabetic acro-necrosis
CN102172392A (en) Chinese medicine for treating diabetic acro-necrosis
CN102091266A (en) Traditional Chinese medicine for treating diabetic extremital gangrene

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110921